Home › Germ Cell and Embryonal Cancer › Georgia
Germ Cell and Embryonal Cancer clinical trials in Georgia
3 studies for Germ Cell and Embryonal Cancer are looking for participants at sites in Georgia.
Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors
- Children's Healthcare of Atlanta - Arthur M Blank Hospital, Atlanta
- Augusta University Medical Center, Augusta
- Atrium Health Navicent, Macon
- and 1 more
RecruitingPhase 3
All ages · All sexes · Updated Aug 25, 2026 · NCT03067181Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors
- Winship Cancer Institute, Emory University, Atlanta
RecruitingPhase 1
Ages 15 and older · All sexes · Updated Aug 25, 2026 · NCT06276491A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
- University Cancer and Blood Center, Athens
RecruitingPhase 1/2
Ages 12 and older · All sexes · Updated May 27, 2026 · NCT03093116From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.